Press Releases

Oct 1, 2025 – Methapharm is pleased to announce that the address of their Canadian headquarters and Importation office will be changing effective October 01, 2025. Please see link below for further details.
June 2, 2025 – Methapharm is pleased to announce that it has been appointed the Canadian distributor for ANDROCUR (cyproterone) tablets and is now supplying pharmacies across the country.
May 21, 2024 – Methapharm Announces Partnership With Bosch Healthcare Solutions GmbH as the Distributor of the Newest FDA-Cleared FeNO Device, Vivatmo Pro, in the United States.
April 15, 2024 – VVT Medical Ltd. appoints Methapharm as Distributor of ScleroSafe in the US
December 1, 2023 – Methapharm appointed as Canadian distributor for KENGREXAL (cangrelor)
November 16, 2023 – Methapharm appointed as Canadian distributor for RESOTRAN (prucalopride)
June 5, 2023 – CHIESI appoints Methapharm as Canadian Distributor for CLEVIPREX® (clevidipine)
April 7, 2022 – Methapharm to present at the 2022 Bloom Burton & Co. Healthcare Investor Conference
February 1, 2022 – Methapharm appointed US marketer for ASCLERA®
December 24, 2021 – Methapharm expands diagnostic imaging collaboration to include technical service for contract media injectors
July 29, 2020 - New Partnership to Offer Ready-To-Use Sterile Methacholine Solution Kits
July 14, 2020 - Methapharm launches PEYONA® in Canada for use in Neonatal Intensive Care Units
June 29, 2020 - Methapharm is pleased to announce that it has been appointed the Canadian distributor for SALAGEN® (Pilocarpine Hydrochloride Tablets).
November 27, 2019 - Methapharm announces Canadian launch of ARIDOL® (mannitol inhalation powder).
April 22, 2019 – Methapharm to present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
February 4, 2019 – Methapharm announces development agreement with Biointerfaces Institute of McMaster University
December 13, 2018 - Methapharm announces US launch of ARIDOL® (mannitol inhalation powder)
November 8, 2018 - Methapharm Inc. announces participation in Triumvira Immunologics Inc. Convertible Debenture
September 18, 2017 - Adienne SA appoints Methapharm as Canadian distributor for TEPADINA (Thiotepa for injection, BP)
February 1, 2017 - Guerbet, the global specialist in contrast agents and solutions for medical imaging, announced that Methapharm will promote and distribute all Guerbet products in Canada
December 19, 2016 - Methapharm launches CUROSURF in Canada
April 13, 2016 - Methapharm is pleased to announce that it has been appointed the Canadian distributor for the Naprosyn, Anaprox, and Toradol brands
March 21, 2016 - SERB SA appoints Methapharm as Canadian distributor for CYANOKIT.
May 20, 2014 - Methapharm Appointed as Canadian Distributor of Fucithalmic Viscous Eye Drops
March 24, 2014 - Methapharm is pleased to announce it has been appointed as the Canadian distributor for Lipiodol and Patent Blue V
April 4, 2013 - Methapharm is pleased to announce that it has successfully passed inspections from the State of Florida’s Division of Drugs, Devices and Cosmetics.
May 4, 2009 - Methapharm appointed Canadian distributor for Erythrocin IV
October 21, 2008 - Methapharm implements Axway’s Synchrony ePedigree solution.
March 19, 2008 - Methapharm implements Lorenz docuBridge®eCTD solution.
October 1, 2007 - Methapharm receives VAWD® accreditation from NABP®.
September 2006 - Methapharm Opens New European Affiliate Office
February 19, 2004 - Methapharm Opens New Canadian Distribution Centre